The American Diabetes Association Receives Health Equity Grant from the Pfizer Foundation to Help Improve the Health of Black Communities in the U.S. | ADA
Pfizer CEO eyes $90B Lilly, Novo battle in diabetes, obesity
Pfizer Inc. on Twitter: "#Diabetes is one of the most serious global health issues of the 21st century. However, type 2 #diabetes can be managed by adopting a healthy lifestyle combined with
Diabetes-Anstieg bei Kindern: Ist Corona die Ursache? - Berliner Morgenpost
Pfizer Pays Biocon $200M Up Front in Global Marketing Agreement for Diabetes Therapies
Disappointment for Pfizer's Lyrica in HIV and diabetes studies - PMLiVE
Pfizer - Today is World Diabetes Day! We are determined to further research on therapies for life-threatening diseases like diabetes. | Facebook
Lebenswertes Leben trotz Diabetes | Pfizer Corporation Austria, 12.11.2015
March » 2021 » Diabetes Institute » College of Medicine » University of Florida
Ex-Pfizer researchers stole secrets to launch diabetes drug, lawsuit says | Reuters
Oral small molecule GLP-1 receptor agonist danuglipron (PF-06882961) results in glucose lowering and body weight loss over 16 weeks in adults with type 2 diabetes - Media Centre | EASD
NIH research highlights increased post-COVID-19 risk of pediatric diabetes, Pfizer vaccine's effectiveness in preventing MIS-C in adolescents and teens | AHA News
Pfizer Inc. on Twitter: "Type 2 diabetes #T2D is a chronic disease characterized by abnormally high blood sugar levels, and adults with diabetes are two to three times more likely to have
Pfizer Inc. on Twitter: "#Diabetes is one of the most serious chronic health issues we face today. RT to spread awareness #2017ADA https://t.co/KuIFyzmi46" / Twitter
AstraZeneca's diabetes drug Farxiga fails in COVID-19 study | Reuters
Pfizer's SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes
Pfizer accuses former employees of 'treachery' in stealing trade secrets to form Regor Therapeutics | Fierce Biotech
Pfizer sues over trade secret theft | C&EN Global Enterprise
Pfizer licenses immune tolerance therapy for type 1 diabetes
Diabetes New Zealand
Pfizer sues two former employees for stealing trade secrets
The Future of Diabetes | Pfizer
